Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. L. Hornick
Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Coxsackievirus Type B3 Is a Potent Oncolytic Virus Against KRAS-Mutant Lung Adenocarcinoma
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
ΙκΒ Kinase Α Is Required for Development and Progression of KRAS-mutant Lung Adenocarcinoma.
Cancer Research
Cancer Research
Oncology
Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung Cancers
Cancer Discovery
Oncology
P2.02-067 LKB1 Loss Is Associated With DNA Hypomethylation in Human Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Suppression of STING Associated With LKB1 Loss in KRAS-driven Lung Cancer
Cancer Discovery
Oncology
Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
P2.01-09 Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Is Aggressive Digital Papillary Adenocarcinoma Really Aggressive Digital Papillary Adenocarcinoma?
Dermatology Practical & Conceptual
ERRα Is an Aggressive Factor in Lung Adenocarcinoma Indicating Poor Prognostic Outcomes
Cancer Management and Research
Oncology